Androgens control the development, growth and function of target tissues, such as the prostate, a major site of both benign and malignant growth in men. 5a-Reductase converts testosterone, the major circulating androgen in men, to dihydrotestosterone, a process believed to amplify the androgenic signal. Two different isozymes of 5a-reductase are present in rats, humans and other animals. The type 2 isozyme is critical for normal male development. Androgenic responses may depend on which isozyme is in a cell and this will be tested with an androgen-responsive reporter gene in cells designed to express components of this system. Testosterone and dihydrotestosterone may also control the expression of separate genes and this possibility will be investigated. Excessive dihydrotestosterone or 5a-reductase activity has been implicated in a variety of androgen-dependent pathological conditions including benign prostatic hyperplasia, acne, alopecia, and female idiopathic hirsutism. Inhibition of 5a-reductase has been proposed as a method to treat these conditions as well as a chemopreventative for prostate cancer, since the growth and function of this gland is dependent on dihydrotestosterone and most prostate cancers are initially androgen-dependent. Although a variety of synthetic 5a-reductase inhibitor have been developed, the first of these to be tested clinically (finasteride) has had limited efficacy. A variety of natural compounds that inhibit 5a-reductase in vitro have been identified. Some of these compounds are pytochemicals that are part of our diet. These compounds may modulate 5a-reductase activity in vivo and in so doing alter normal and malignant cellular growth and function. Naturally occurring 5a-reductase inhibitors and synthetic analogs will be tested in bioassays including growth and function of normal and malignant cells in culture, testosterone-induced accessory sex gland growth in rats and androgen-dependent growth of hamster sebaceous glands. The effect of these 5a-reductase inhibitors on the growth of androgen-dependent human prostate tumors xenografts in nude mice will be examined. Very little is known about the functional domains of 5a-reductase or the mechanism by which this enzyme reduces its various substrates. Development of new inhibitors of this enzyme as well as understanding the mechanism of inhibition of those inhibitors presently in hand would benefit from a more detailed picture of the steroid-binding domain of this protein. A recently developed photoaffinity-label will be used to identify amino acid residues in the steroid-binding domain of the isozymes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK041670-11
Application #
2905396
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Akolkar, Beena
Project Start
1989-08-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Liao, S; Lin, J; Dang, M T et al. (2001) Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Arch Dermatol Res 293:200-5
Kokontis, J M; Wagner, A J; O'Leary, M et al. (2001) A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene 20:659-68
Kao, Y H; Hiipakka, R A; Liao, S (2000) Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141:980-7
Kokontis, J M; Hay, N; Liao, S (1998) Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 12:941-53
Deplewski, D; Liao, S; Rosenfield, R L (1997) Preputial sebocyte 5alpha-reductase isoform specificity. Endocrinology 138:4416-20
Liang, T; Liao, S (1997) Growth suppression of hamster flank organs by topical application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase. J Invest Dermatol 109:152-7
Taylor, M F; Bhattacharyya, A K; Rajagopalan, K et al. (1996) Photoaffinity labeling of rat steroid 5 alpha-reductase (isozyme-1) by a benzophenone derivative of a 4-methyl-4-azasteroid. Steroids 61:323-31
Umekita, Y; Hiipakka, R A; Kokontis, J M et al. (1996) Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci U S A 93:11802-7
Liao, S; Hiipakka, R A (1995) Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun 214:833-8
Liao, S; Umekita, Y; Guo, J et al. (1995) Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96:239-43

Showing the most recent 10 out of 19 publications